Causes & Symptoms

Understanding risk factors and early symptoms helps prompt diagnosis. Causes often relate to altered tubal anatomy or function.

• Common causes / risk factors: previous pelvic infection (PID), prior tubal surgery, previous ectopic pregnancy, assisted reproduction techniques, smoking, and congenital tubal abnormalities.
• Typical symptoms: unilateral pelvic or abdominal pain, vaginal bleeding or spotting, delayed menses, shoulder tip pain (referred pain from diaphragmatic irritation), lightheadedness or fainting if bleeding is significant.
• When to seek urgent care: sudden severe abdominal pain, dizziness, fainting, or signs of shock — these may indicate tubal rupture and internal haemorrhage.

Non‑Surgical / Lifestyle Care

Where appropriate, non‑surgical measures and lifestyle adjustments support recovery and reduce risk for future ectopic pregnancy.

• Avoid smoking and tobacco — smoking is a modifiable risk factor that impairs tubal motility.
• Prompt evaluation for pelvic infections and early treatment of sexually transmitted infections to reduce scarring.
• Follow scheduled monitoring after medical management (serial beta‑hCG) and avoid strenuous activity until cleared by your physician.
• Discuss contraception and timing of future conception with your infertility specialist; early counselling can guide safer reproductive planning.
• Mental health support: anxiety after an ectopic pregnancy is common — consider counselling or support groups.

Treatment & Surgical Options

Treatment is tailored to clinical stability, location and size of the ectopic pregnancy, beta‑hCG levels, and the patient’s fertility goals. Options include expectant, medical, and surgical management.

Expectant Management

For small, non‑progressing ectopic pregnancies with low and declining beta‑hCG levels and no pain or bleeding, close observation with serial beta‑hCG and ultrasound may be chosen. Requires reliable follow‑up.

Medical Management (Methotrexate)

Methotrexate is a folate antagonist used as a single‑dose or multi‑dose protocol to medically resolve certain ectopic pregnancies. Indications typically include hemodynamically stable patients, absence of rupture, and selected beta‑hCG criteria.

• Pre‑treatment evaluation: baseline beta‑hCG, transvaginal ultrasound to confirm no intrauterine pregnancy and no significant free fluid, liver and renal function tests.
• Follow‑up: serial beta‑hCG monitoring until undetectable; avoid conception for at least 3 months after methotrexate.
• Side effects: nausea, stomatitis, transient liver enzyme elevation; rare serious toxicity requires immediate attention.

Surgical Options

Surgery is indicated for unstable patients, suspected rupture, large ectopic mass, or contraindications to methotrexate. Minimally invasive laparoscopy is the preferred surgical approach in most cases.

• Laparoscopic salpingostomy: incision on the fallopian tube to remove the ectopic pregnancy while preserving the tube. Preferred when fertility preservation is a priority and contralateral tube is abnormal.
• Laparoscopic salpingectomy: removal of the affected fallopian tube; indicated when the tube is severely damaged, bleeding is significant, or patient has completed childbearing.
• Open surgery (laparotomy): reserved for unstable patients or when extensive haemorrhage requires rapid control.
• Intraoperative considerations: blood loss management, inspection of contralateral tube, discussion of fertility implications and future reproductive planning

Frequently Asked Questions